Details for Patent: 5,356,896
✉ Email this page to a colleague
Summary for Patent: 5,356,896
Title: | Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor compound |
Abstract: | A pharmaceutical dosage form comprising an HMG-CoA reductase inhibitor compound, e.g., fluvastatin sodium, is disclosed which is stabilized against pH-related degradation by an alkaline stabilizing medium capable of imparting a pH of at least 8 to an aqueous solution or dispersion of the composition. |
Inventor(s): | Kabadi; Mohan B. (Marlboro, NJ), Vivilecchia; Richard V. (Rockaway, NJ) |
Assignee: | Sandoz Ltd. (Basel, CH) |
Application Number: | 07/995,252 |
Patent Claim Types: see list of patent claims | Composition; Compound; Formulation; Dosage form; Delivery; Use; |
Drugs Protected by US Patent 5,356,896
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,356,896
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 401870 | ⤷ Try a Trial | |||
Austria | 401872 | ⤷ Try a Trial | |||
Austria | A190595 | ⤷ Try a Trial | |||
Austria | A244992 | ⤷ Try a Trial | |||
Australia | 3006992 | ⤷ Try a Trial | |||
Australia | 661075 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |